Page last updated: 2024-10-29

iohexol and Yolk Sac Tumor

iohexol has been researched along with Yolk Sac Tumor in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y1
Zheng, Y1
Lin, J1
Xu, G1
Cai, A1
Chen, R1
Wu, M1

Other Studies

1 other study available for iohexol and Yolk Sac Tumor

ArticleYear
Radiological-pathological correlation of yolk sac tumor in 20 patients.
    Acta radiologica (Stockholm, Sweden : 1987), 2016, Volume: 57, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Endodermal Sinus Tumor; Female; Humans;

2016